Effect of 8 weeks esomeprazole therapy on lung function in asthmatic patients with gastroesophageal reflux disease

S. Serebrova, N. Berdnikova, O. Dobrovolsky, A. Starodubtsev (Moscow, Russian Federation)

Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Session: Traditional and novel approaches to assess and achieve asthma control
Session type: Electronic Poster Discussion
Number: 273
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Serebrova, N. Berdnikova, O. Dobrovolsky, A. Starodubtsev (Moscow, Russian Federation). Effect of 8 weeks esomeprazole therapy on lung function in asthmatic patients with gastroesophageal reflux disease. Eur Respir J 2007; 30: Suppl. 51, 273

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The frequency of gastroesophageal reflux disease and the therapeutic effect of rabeprazole in patients with asthma
Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges
Year: 2010

Evaluation of lung function in children with asthma and gastroesophageal reflux disease association
Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases
Year: 2012


Induced sputum substance P in children with difficult-to-treat bronchial asthma and gastroesophageal reflux: Effect of esomeprazole therapy
Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers
Year: 2012


Cisapride treatment of gastroesophageal reflux in children with chronic respiratory disease
Source: Eur Respir J 2005; 26: Suppl. 49, 165s
Year: 2005

The evaluation of bronchial hyperreactivity in gastroesophageal reflux disease and the outcome of antiinflamatory therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 133s
Year: 2004

Increased gastro-oesophageal reflux disease in patients with severe COPD.
Source: Eur Respir J 2004; 24: 1074
Year: 2004


Determination of levels of markers of systemic inflammation in patients with chronic bronchitis in combination with concomitant gastroesophageal reflux disease
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020

The incidence of laryngopharyngeal reflux in patients with COPD and the effect of laryngopharyngeal reflux on the rate of exacerbations of COPD and COPD symptom scores
Source: Eur Respir J 2007; 30: Suppl. 51, 558s
Year: 2007

Effect of gastroesophageal reflux (GER) on the progression of pulmonary fibrosis
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019


Association of esophageal dysfunction with therapeutic efficacy of baclofen in patients with refractory gastroesophageal reflux-induced chronic cough
Source: International Congress 2017 – Miscellaneous clinical problems
Year: 2017

The prevalence of gastroesophageal reflux disease in patients with asthma and COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 301s
Year: 2005

Association of gastroesophageal reflux disease (GERD) and bronchoscopically diagnosed chronic airway diseases in children
Source: Eur Respir J 2007; 30: Suppl. 51, 400s
Year: 2007

Ex iuvantibus trial with omeprazole in patients with cronic cough and silent gastroesophageal reflux desease(GERD)
Source: Eur Respir J 2002; 20: Suppl. 38, 450s
Year: 2002

Extraesophageal reflux (EER)­-diagnostics and therapy in respiratory patients
Source: International Congress 2017 – Clinical problems in lung diseases
Year: 2017

Increased gastro-oesophageal reflux disease in patients with severe COPD
Source: Eur Respir J 2004; 23: 841-845
Year: 2004



Effect of acidification of distal esophagus on cough sensitivity in patients with gastroesophageal reflux disease
Source: Annual Congress 2003 - Cough and sleep disorders
Year: 2003


Proportion of gastroesophageal reflux symptoms in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 59s
Year: 2005

Effects of pantoperazole on pulmonary function tests of chronic obstructive pulmonary disease patients, with and without gastro esophageal reflux
Source: Annual Congress 2011 - Airways disease comorbidities and general aspects
Year: 2011

The prevalence of gastroesophageal reflux disease (GERD) in bronchiectasis and COPD
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008


The effect of rabeprazole on cough related to gastro-oesophageal reflux
Source: Eur Respir J 2005; 26: Suppl. 49, 302s
Year: 2005